123 related articles for article (PubMed ID: 25609576)
1. How unique is pure erythroid leukaemia? A retrospective analysis of seven cases and review of the literature.
Wong E; Ling V; Westerman D; Morgan S; Juneja S
J Clin Pathol; 2015 Apr; 68(4):301-5. PubMed ID: 25609576
[TBL] [Abstract][Full Text] [Related]
2. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S
Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165
[TBL] [Abstract][Full Text] [Related]
3. Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification.
Liu W; Hasserjian RP; Hu Y; Zhang L; Miranda RN; Medeiros LJ; Wang SA
Mod Pathol; 2011 Mar; 24(3):375-83. PubMed ID: 21102413
[TBL] [Abstract][Full Text] [Related]
4. Acute myeloid leukaemia and myelodysplastic syndromes with 50% or greater erythroblasts: a diagnostic conundrum.
Wong E; Juneja S
Pathology; 2015 Jun; 47(4):289-93. PubMed ID: 25938365
[TBL] [Abstract][Full Text] [Related]
5. The morphological subcategories of acute monocytic leukemia (M5a and M5b) share similar immunophenotypic and cytogenetic features and clinical outcomes.
Villeneuve P; Kim DT; Xu W; Brandwein J; Chang H
Leuk Res; 2008 Feb; 32(2):269-73. PubMed ID: 17689610
[TBL] [Abstract][Full Text] [Related]
6. Acute leukaemia with a pure erythroid phenotype: under-recognized morphological and cytogenetic signatures associated universally with primary refractory disease and a dismal clinical outcome.
Park DC; Ozkaya N; Lovitch SB
Histopathology; 2017 Aug; 71(2):316-321. PubMed ID: 28261852
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases.
Morel P; Hebbar M; Lai JL; Duhamel A; Preudhomme C; Wattel E; Bauters F; Fenaux P
Leukemia; 1993 Sep; 7(9):1315-23. PubMed ID: 8371581
[TBL] [Abstract][Full Text] [Related]
8. Study of clinical, haematological and cytogenetic profile of patients with acute erythroid leukaemia.
Linu JA; Udupa MN; Madhumathi DS; Lakshmaiah KC; Babu KG; Lokanatha D; Babu MS; Lokesh KN; Rajeev LK; Rudresha AH
Ecancermedicalscience; 2017; 11():712. PubMed ID: 28144286
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic abnormalities and monosomal karyotypes in children and adolescents with acute myeloid leukemia: correlations with clinical characteristics and outcome.
Manola KN; Panitsas F; Polychronopoulou S; Daraki A; Karakosta M; Stavropoulou C; Avgerinou G; Hatzipantelis E; Pantelias G; Sambani C; Pagoni M
Cancer Genet; 2013 Mar; 206(3):63-72. PubMed ID: 23411131
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological analysis of near-tetraploidy/tetraploidy acute myeloid leukaemia.
Pang CS; Pettenati MJ; Pardee TS
J Clin Pathol; 2015 Mar; 68(3):236-40. PubMed ID: 25563333
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cytogenetics and clinical manifestations between M5a and M5b of acute monocytic leukemia.
Liu LB; Li L; Zou P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):654-7. PubMed ID: 16928293
[TBL] [Abstract][Full Text] [Related]
12. Acute monocytic leukemia (French-American-British classification M5) does not have a worse prognosis than other subtypes of acute myeloid leukemia: a report from the Eastern Cooperative Oncology Group.
Tallman MS; Kim HT; Paietta E; Bennett JM; Dewald G; Cassileth PA; Wiernik PH; Rowe JM;
J Clin Oncol; 2004 Apr; 22(7):1276-86. PubMed ID: 14970186
[TBL] [Abstract][Full Text] [Related]
13. [Study on the transformation from myelodysplastic syndromes into acute leukemias].
Shi J; Shao Z; Liu H; Li K; Song L; Zhang Y; Zheng Y; Chen G; Chu Y; He H; Zhao M; He G; Feng B; Hao Y; Yang T; Yang C
Zhonghua Xue Ye Xue Za Zhi; 2001 Jul; 22(7):351-4. PubMed ID: 11877096
[TBL] [Abstract][Full Text] [Related]
14. Morphologic, immunologic and cytogenetic studies in erythroleukaemia: evidence for multilineage involvement and identification of two distinct cytogenetic-clinicopathological types.
Cuneo A; Van Orshoven A; Michaux JL; Boogaerts M; Louwagie A; Doyen C; Dal Cin P; Fagioli F; Castoldi G; Van den Berghe H
Br J Haematol; 1990 Jul; 75(3):346-54. PubMed ID: 2386768
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
Wang XB; Zheng JE; Gu JX; Yao JX; Yang J; Liu J; Li XQ; He YL; Yu JM; Wei J; Liu ZP; Huang SA
Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475
[TBL] [Abstract][Full Text] [Related]
16. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001.
Mauritzson N; Albin M; Rylander L; Billström R; Ahlgren T; Mikoczy Z; Björk J; Strömberg U; Nilsson PG; Mitelman F; Hagmar L; Johansson B
Leukemia; 2002 Dec; 16(12):2366-78. PubMed ID: 12454741
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
[TBL] [Abstract][Full Text] [Related]
18. Acute erythroid leukemia is enriched in NUP98 fusions: a report from the Children's Oncology Group.
Chisholm KM; Heerema-McKenney AE; Choi JK; Smith J; Ries RE; Hirsch BA; Raimondi SC; Alonzo TA; Wang YC; Aplenc R; Sung L; Gamis AS; Meshinchi S; Kahwash SB
Blood Adv; 2020 Dec; 4(23):6000-6008. PubMed ID: 33284945
[TBL] [Abstract][Full Text] [Related]
19. [Spontaneous remission of congenital leukemia cutis].
Eberst E; Michel B; Stoebner P; Dandurand M; Meunier L
Ann Dermatol Venereol; 2011; 138(8-9):586-90. PubMed ID: 21893232
[TBL] [Abstract][Full Text] [Related]
20. A rare cytogenetic presentation of acute myeloid leukemia (AML-M2).
Kumari P; LingappaKavitha B; Obula Reddy C; Mangalagowri M; Madhumathi DS; Mahadeva Prasad M; Raghavendra HV; Premalata CS; Lakshmaiah KC; Mir Mazloumi SH
Acta Med Iran; 2012; 50(12):827-30. PubMed ID: 23456526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
